White Paper
Healthspan vs Lifespan: A Framework for Performance Animals
2025
34 pp.
§ Research
Research Library
Curated summaries of peer-reviewed studies, annotated bibliographies, white papers, and a public data-transparency statement. Academic legitimacy is the foundation of applied longevity.
Active Research Themes
Five domains. One discipline.
§ 01
Cellular & Molecular Aging
Senescence, mitochondrial decline, oxidative stress and epigenetic clocks in non-human species.
§ 02
Musculoskeletal Longevity
Tendon, ligament, cartilage and bone biology under repetitive load across the career arc.
§ 03
Metabolic & Endocrine Aging
Insulin sensitivity, cortisol patterning, thyroid function and lipid metabolism as longevity signals.
§ 04
AI & Predictive Veterinary Medicine
Machine learning applied to gait analysis, biomarker interpretation and longitudinal health modelling.
§ 05
Ethics & Welfare Science
Welfare assessment, sentience research and the philosophical foundations of longevity intervention.
Library
Selected Publications
A curated set of summaries, annotated reviews and original white papers. Full PDFs are available on request to qualified researchers and veterinarians.
Summary
Inflammatory Markers as Longevity Signals in the Equine Athlete
2025
12 pp.
Summary
Thermoregulatory Adaptation and Renal Aging in Racing Camels
2024
18 pp.
Summary
Cumulative Load and Tendon Microdamage in High-Output Equines
2024
22 pp.
Annotated Review
Avian Aging Biology: A Comparative Framework for Falconry
2024
40 pp.
White Paper
Welfare-Bounded AI in Veterinary Decision Support
2025
28 pp.
To request full-text access, please contact our team with your institutional affiliation and area of research.
Data Transparency
Our commitment to open science.
IZZ Longevity research is published with explicit disclosure of methods, sample sizes, statistical assumptions, conflicts of interest, and limitations. Where datasets can be shared without compromising animal privacy or welfare, we make them available to qualified researchers.
We do not publish results that cannot be independently scrutinised. We do not market interventions whose evidence base has not been openly stated. Longevity claims that exceed the evidence are the principal failure mode of this field — and our institutional discipline is to refuse them.